Eastgate Biotech Corp Deferred Revenue
Eastgate Biotech Corp had Deferred Revenue of $94.84 thousand as of 2017-06-30, per its 10-Q filed 2018-12-18.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2019-03-04
- 2017-06-30: Deferred Revenue $94.84K.
- 2017-03-31: Deferred Revenue $93.33K.
- 2016-12-31: Deferred Revenue $92.52K.
- 2015-06-30: Deferred Revenue $9.82K.
| Period end | Deferred Revenue |
|---|---|
| 2017-06-30 | $94.84K 10-Q · filed 2018-12-18 |
| 2017-03-31 | $93.33K 10-Q · filed 2018-08-17 |
| 2016-12-31 | $92.52K 10-Q · filed 2019-03-04 |
| 2015-06-30 | $9.82K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $65.41K 10-Q · filed 2015-05-20 |